Gene · 7436
Papers2,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dietary Sources, Sex, and rs5888 (SCARB1) as Modulators of Vitamin A's Effect on Cardiometabolic Health. | Int J Mol Sci | 2023 | 37762456 | PubTator, text mining | PubMed |
| Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments. | Int J Mol Sci | 2023 | 37762244 | PubTator, text mining | PubMed |
| Data Mining of Microarray Datasets in Translational Neuroscience. | Brain Sci | 2023 | 37759919 | PubTator, text mining | PubMed |
| Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis. | Lipids Health Dis | 2023 | 37736721 | PubTator, text mining | PubMed |
| Identification and validation of a fatty acid metabolism gene signature for the promotion of metastasis in liver cancer. | Oncol Lett | 2023 | 37736554 | PubTator, text mining | PubMed |
| Regulation of the hippocampal translatome by Apoer2-ICD release. | Mol Neurodegener | 2023 | 37726747 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals upregulated host metabolisms and downregulated immune responses or cell death induced by acute African swine fever virus infection. | Front Vet Sci | 2023 | 37720481 | PubTator, text mining | PubMed |
| Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. | J Hematol Oncol | 2023 | 37700339 | PubTator, text mining | PubMed |
| Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension? | Int J Mol Sci | 2023 | 37686169 | PubTator, text mining | PubMed |
| Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression. | Acta Pharm Sin B | 2023 | 37655336 | PubTator, text mining | PubMed |
| Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease. | NPJ Parkinsons Dis | 2023 | 37652906 | PubTator, text mining | PubMed |
| Endothelial Cell APOE3 Regulates Neurovascular, Neuronal, and Behavioral Function. | Arterioscler Thromb Vasc Biol | 2023 | 37650329 | PubTator, text mining | PubMed |
| Identification and validation of potential hypoxia-related genes associated with coronary artery disease. | Front Physiol | 2023 | 37637145 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers? | Life (Basel) | 2023 | 37629489 | PubTator, text mining | PubMed |
| Obesity Contributes to Transformation of Myometrial Stem-Cell Niche to Leiomyoma via Inducing Oxidative Stress, DNA Damage, Proliferation, and Extracellular Matrix Deposition. | Genes (Basel) | 2023 | 37628676 | PubTator, text mining | PubMed |
| Multiple LDLR class A repeats on very-low-density lipoprotein receptor promote the cross-species transmission of Semliki Forest virus. | MedComm (2020) | 2023 | 37614966 | PubTator, text mining | PubMed |
| Apolipoprotein E and viral infection: Risks and Mechanisms. | Mol Ther Nucleic Acids | 2023 | 37588688 | PubTator, text mining | PubMed |
MicroRNA expression profile of human umbilical vein endothelial cells in response to coxsackievirus A10 infection reveals a potential role of miR-143-3p in maintaining the integrity of the blood-brain barrier. | Front Cell Infect Microbiol | 2023 | 37577373 | PubTator, text mining | PubMed |
| The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy. | Int J Mol Sci | 2023 | 37569401 | PubTator, text mining | PubMed |
| Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling. | Clinics (Sao Paulo) | 2023 | 37557005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7436/papers?page=8